🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hind Rafei

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-5724-4183

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial”.

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

Nature Medicine(2024)10.1038/s41591-023-02785-8

N/A

4.0DataRank · unranked

468 citations

Ye Li, Rafet Başar, Hind Rafei, May Daher, Jinzhuang Dou +31 more

Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

Journal of Clinical Oncology(2021)10.1200/jco.20.02608

N/A

2.1DataRank · unranked

66 citations

Ruitao Lin, David Marín, Hind Rafei, Mustafa Bdiwi, Peter F. Thall +38 more

Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering

Science Advances(2023)10.1126/sciadv.add6997

N/A

0DataRank · unranked

107 citations

Vakul Mohanty, Jinzhuang Dou, Yuefan Huang, Pinaki P. Banerjee, Qi Miao +25 more

Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancer

Immunological Reviews(2023)10.1111/imr.13255

N/A

0DataRank · unranked

35 citations

Katayoun Rezvani, Hind Rafei, Ye Li

Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD

Cancer Cell(2024)10.1016/j.ccell.2024.07.007

N/A

0DataRank · unranked

86 citations

May Daher, Jinzhuang Dou, Sufang Li, Rafet Başar, Hind Rafei +29 more

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0096

N/A

0DataRank · unranked

55 citations

Rafet Başar, May Daher, Hind Rafei, Ping Li, Nadima Uprety +42 more

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML

Science Translational Medicine(2024)10.1126/scitranslmed.adp0004

N/A

0DataRank · unranked

31 citations

Anand K. Singh, Rafet Başar, Nadima Uprety, Ye Li, Huihui Fan +45 more

Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial

American Journal of Hematology(2024)10.1002/ajh.27254

N/A

0DataRank · unranked

5 citations

Kamal Alzahrani, Hagop M. Kantarjian, Denái R. Milton, Alison Gulbis, Koji Sasaki +18 more

Phase I/II study of TROP2 CAR engineered IL15-transduced cord blood-derived NK cells delivered intraperitoneally for the management of platinum resistant ovarian cancer, mesonephric-like adenocarcinoma, and pancreatic cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps5626

N/A

0DataRank · unranked

9 citations

Hind Rafei, Rafet Başar, Pinaki P. Banerjee, Zeyad Metwalli, Kathryn Lito +13 more

CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells

Nature(2025)10.1038/s41586-025-09087-8

N/A

0DataRank · unranked

48 citations

Rafet Başar, Sunil Acharya, Yu-Sung Hsu, Pinghua Liu, Deqiang Zhang +53 more

Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency

Cancer Cell(2025)10.1016/j.ccell.2025.07.021

N/A

0DataRank · unranked

37 citations

Rafet Başar, Jeong-Min Park, Nadima Uprety, Rejeena Shrestha, Francia Reyes Silva +31 more

Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells

Cell Reports(2025)10.1016/j.celrep.2024.115122

N/A

0DataRank · unranked

11 citations

Achintyan Gangadharan, Pinaki P. Banerjee, Ye Li, Andy G.X. Zeng, Hind Rafei +18 more

Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia

Frontiers in Immunology(2022)10.3389/fimmu.2022.1018047

N/A

0DataRank · unranked

3 citations

Vahid Afshar‐Kharghan, Mayela Carolina Mendt, Robert Sackstein, Mark R. Tanner, Uday Popat +19 more